Market closedNon-fractional
Sanara MedTech/SMTI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Sanara MedTech
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Ticker
SMTI
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Fort Worth, United States
Employees
108
Website
sanaramedtech.com
Sanara MedTech Metrics
BasicAdvanced
$278M
Market cap
-
P/E ratio
-$0.59
EPS
1.67
Beta
-
Dividend rate
Price and volume
Market cap
$278M
Beta
1.67
Financial strength
Current ratio
1.348
Quick ratio
0.945
Long term debt to equity
24.166
Total debt to equity
27.202
Interest coverage (TTM)
-10.22%
Management effectiveness
Return on assets (TTM)
-7.25%
Return on equity (TTM)
-11.89%
Valuation
Price to revenue (TTM)
3.948
Price to book
6.14
Price to tangible book (TTM)
-62.37
Price to free cash flow (TTM)
-78.918
Growth
Revenue change (TTM)
26.98%
Earnings per share change (TTM)
-21.18%
3-year revenue growth (CAGR)
58.52%
3-year earnings per share growth (CAGR)
-0.33%
What the Analysts think about Sanara MedTech
Analyst Ratings
Majority rating from 1 analysts.
Sanara MedTech Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$19M
5.11%
Net income
-$1.7M
750.00%
Profit margin
-9.18%
712.39%
Sanara MedTech Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.22
-$0.13
-$0.03
-$0.21
-
Expected
-$0.13
-
-$0.13
-$0.07
-$0.21
Surprise
69.23%
-
-76.92%
200.00%
-
Sanara MedTech News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sanara MedTech stock?
Sanara MedTech (SMTI) has a market cap of $278M as of July 27, 2024.
What is the P/E ratio for Sanara MedTech stock?
The price to earnings (P/E) ratio for Sanara MedTech (SMTI) stock is 0 as of July 27, 2024.
Does Sanara MedTech stock pay dividends?
No, Sanara MedTech (SMTI) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Sanara MedTech dividend payment date?
Sanara MedTech (SMTI) stock does not pay dividends to its shareholders.
What is the beta indicator for Sanara MedTech?
Sanara MedTech (SMTI) has a beta rating of 1.67. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Sanara MedTech stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.